Showing results (241-250 of 332) with videos related to

Sort By:
Pageof 34
Blood Advances|August 26, 2018
Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP studySalyka Sengsayadeth, Katie S Gatwood, Ariane Boumendil, et al.
The Lancet. Haematology|May 28, 2023
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 studyPierre Peterlin, Yannick Le Bris, Pascal Turlure, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2014
Unrelated cord blood transplantation for patients with primary or secondary myelofibrosisMarie Robin, Federica Giannotti, Eric Deconinck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q DeletionLaurent Garderet, Dimitris Ziagkos, Anja van Biezen, et al.
Blood|December 19, 2009
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceLionel Adès, Agnes Guerci, Emmanuel Raffoux, et al.
American Journal of Hematology|October 27, 2020
Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide studyJean-Baptiste Bossard, Jean-Baptiste Beuscart, Marie Robin, et al.
Acta Haematologica|January 5, 2023
On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid LeukemiaCharles Guisnel, Luciane Schirmer, Stéphane Morisset, et al.
Leukemia|January 30, 2020
Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantationRathana Kim, Nicolas Boissel, Aurore Touzart, et al.
Blood Advances|February 11, 2021
Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohortEdmond Chiche, Ramy Rahmé, Sarah Bertoli, et al.
Haematologica|June 25, 2026
Prognostic impact of t(9;11) and del(7q) as intermediate-risk abnormalities in acute myeloid leukemia following allo-transplant: an Acute Leukemia Working Party study from the European Society for Blood and Marrow TransplantationIman Abou Dalle, Jacques-Emmanuel Galimard, Ali Bazarbachi, et al.
Pageof 34